HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ljubica Harhaji Selected Research

Gentian Violet (Violet, Crystal)

6/2008Modulation of tumor necrosis factor-mediated cell death by fullerenes.
3/2008Synergistic antiglioma action of hyperthermia and nitric oxide.
5/2006Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene.
7/2005[Pt(HPxSC)Cl(3)], a novel platinum(IV) compound with anticancer properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ljubica Harhaji Research Topics

Disease

7Glioma (Gliomas)
09/2008 - 01/2006
5Fibrosarcoma
06/2008 - 02/2004
4Neoplasms (Cancer)
06/2008 - 02/2004
3Necrosis
06/2008 - 05/2006
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2008 - 03/2007
2Astrocytoma (Pilocytic Astrocytoma)
07/2005 - 04/2005
1Brain Neoplasms (Brain Tumor)
09/2008
1Melanoma (Melanoma, Malignant)
09/2008
1Mitochondrial Diseases (Mitochondrial Disease)
06/2008
1Hyperthermia
03/2008
1Hyperglycemia
03/2007
1Inflammation (Inflammations)
03/2007
1Acidosis
01/2006

Drug/Important Bio-Agent (IBA)

5Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2008 - 02/2004
4CytokinesIBA
09/2008 - 01/2006
4Gentian Violet (Violet, Crystal)FDA Link
06/2008 - 07/2005
4CaspasesIBA
06/2008 - 05/2006
3Reactive Oxygen Species (Oxygen Radicals)IBA
06/2008 - 05/2006
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2008 - 07/2007
23-phenyl-4,5-dihydro-5-isoxazole acetic acidIBA
09/2008 - 03/2007
2Coloring Agents (Dyes)IBA
06/2008 - 05/2006
2Acetylcysteine (Siran)FDA LinkGeneric
06/2008 - 05/2006
2hydroxide ionIBA
06/2008 - 05/2006
2AntioxidantsIBA
06/2008 - 05/2006
2FullerenesIBA
06/2008 - 07/2007
2Propidium (Propidium Iodide)IBA
05/2006 - 07/2005
2Free RadicalsIBA
01/2006 - 02/2004
1Adenosine (Adenocard)FDA LinkGeneric
09/2008
1Messenger RNA (mRNA)IBA
09/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2008
1Nitric Oxide Synthase (NO Synthase)IBA
09/2008
1AntibodiesIBA
06/2008
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2008
1EnzymesIBA
06/2008
1Macrophage Migration-Inhibitory FactorsIBA
06/2008
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2008
1gentiakochianinIBA
05/2008
1XanthonesIBA
05/2008
1gentiacauleinIBA
05/2008
1Fluorescent Dyes (Fluorescent Probes)IBA
03/2008
1AdenineFDA LinkGeneric
03/2008
1Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
03/2008
1Acridine OrangeIBA
03/2008
1S-NitrosoglutathioneIBA
03/2008
1PAPA NONOateIBA
03/2008
1SolventsIBA
07/2007
1SuspensionsIBA
07/2007
1aloe emodinIBA
07/2007
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
07/2007
1AnthraquinonesIBA
07/2007
1Interferon-gamma (Interferon, gamma)IBA
03/2007
1InterleukinsIBA
03/2007
1Streptozocin (Streptozotocin)FDA Link
03/2007
1Annexin A5IBA
05/2006
1benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
05/2006
1isothiocyanic acidIBA
05/2006
1Fluorescein (Funduscein)FDA LinkGeneric
05/2006
1Phosphotransferases (Kinase)IBA
01/2006
1Transcription Factors (Transcription Factor)IBA
01/2006
1DNA (Deoxyribonucleic Acid)IBA
07/2005
1Cisplatin (Platino)FDA LinkGeneric
07/2005
1Pharmaceutical PreparationsIBA
07/2005
1IronIBA
04/2005
1Oxidopamine (6 Hydroxydopamine)IBA
04/2005
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2004
1Therapeutic UsesIBA
02/2004
1Paclitaxel (Taxol)FDA LinkGeneric
02/2004
1DecitabineFDA Link
02/2004

Therapy/Procedure

1Therapeutics
06/2008
1Induced Hyperthermia (Thermotherapy)
03/2008